BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: van Werkhoven MB, Damman J, Daha MR, Krikke C, van Goor H, van Son WJ, Hillebrands J, van Dijk MC, Seelen MA. Novel insights in localization and expression levels of C5aR and C5L2 under native and post-transplant conditions in the kidney. Molecular Immunology 2013;53:237-45. [DOI: 10.1016/j.molimm.2012.08.013] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Burwick RM, Fichorova RN, Dawood HY, Yamamoto HS, Feinberg BB. Urinary excretion of C5b-9 in severe preeclampsia: tipping the balance of complement activation in pregnancy. Hypertension 2013;62:1040-5. [PMID: 24060886 DOI: 10.1161/HYPERTENSIONAHA.113.01420] [Cited by in Crossref: 69] [Cited by in F6Publishing: 36] [Article Influence: 7.7] [Reference Citation Analysis]
2 Castellano G, Franzin R, Sallustio F, Stasi A, Banelli B, Romani M, De Palma G, Lucarelli G, Divella C, Battaglia M, Crovace A, Staffieri F, Grandaliano G, Stallone G, Ditonno P, Cravedi P, Cantaluppi V, Gesualdo L. Complement component C5a induces aberrant epigenetic modifications in renal tubular epithelial cells accelerating senescence by Wnt4/βcatenin signaling after ischemia/reperfusion injury. Aging (Albany NY) 2019;11:4382-406. [PMID: 31284268 DOI: 10.18632/aging.102059] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 14.0] [Reference Citation Analysis]
3 Takano T, Elimam H, Cybulsky AV. Complement-mediated cellular injury. Semin Nephrol. 2013;33:586-601. [PMID: 24161043 DOI: 10.1016/j.semnephrol.2013.08.009] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 4.5] [Reference Citation Analysis]
4 Schröppel B, Heeger PS, Thiessen-Philbrook H, Hall IE, Doshi MD, Weng FL, Reese PP, Parikh CR. Donor Urinary C5a Levels Independently Correlate With Posttransplant Delayed Graft Function. Transplantation 2019;103:e29-35. [PMID: 30451738 DOI: 10.1097/TP.0000000000002494] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
5 Martin IV, Bohner A, Boor P, Shagdarsuren E, Raffetseder U, Lammert F, Floege J, Ostendorf T, Weber SN. Complement C5a receptors C5L2 and C5aR in renal fibrosis. Am J Physiol Renal Physiol 2018;314:F35-46. [PMID: 28903945 DOI: 10.1152/ajprenal.00060.2017] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
6 Li K, Zhou W. Anaphylatoxins in organ transplantation. Semin Immunol 2013;25:20-8. [PMID: 23722015 DOI: 10.1016/j.smim.2013.04.013] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
7 Weiss S, Rosendahl A, Czesla D, Meyer-Schwesinger C, Stahl RA, Ehmke H, Kurts C, Zipfel PF, Köhl J, Wenzel UO. The complement receptor C5aR1 contributes to renal damage but protects the heart in angiotensin II-induced hypertension. Am J Physiol Renal Physiol 2016;310:F1356-65. [PMID: 27053686 DOI: 10.1152/ajprenal.00040.2016] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 4.2] [Reference Citation Analysis]
8 Osman M, Cohen Tervaert JW, Pagnoux C. Avacopan for the treatment of ANCA-associated vasculitis. Expert Rev Clin Immunol 2021;17:717-26. [PMID: 34006155 DOI: 10.1080/1744666X.2021.1932466] [Reference Citation Analysis]
9 Franzin R, Stasi A, Fiorentino M, Stallone G, Cantaluppi V, Gesualdo L, Castellano G. Inflammaging and Complement System: A Link Between Acute Kidney Injury and Chronic Graft Damage. Front Immunol 2020;11:734. [PMID: 32457738 DOI: 10.3389/fimmu.2020.00734] [Cited by in Crossref: 20] [Cited by in F6Publishing: 24] [Article Influence: 10.0] [Reference Citation Analysis]
10 Poppelaars F, van Werkhoven MB, Kotimaa J, Veldhuis ZJ, Ausema A, Broeren SGM, Damman J, Hempel JC, Leuvenink HGD, Daha MR, van Son WJ, van Kooten C, van Os RP, Hillebrands JL, Seelen MA. Critical role for complement receptor C5aR2 in the pathogenesis of renal ischemia-reperfusion injury. FASEB J 2017;31:3193-204. [PMID: 28396344 DOI: 10.1096/fj.201601218R] [Cited by in Crossref: 24] [Cited by in F6Publishing: 15] [Article Influence: 4.8] [Reference Citation Analysis]
11 Laumonnier Y, Karsten CM, Köhl J. Novel insights into the expression pattern of anaphylatoxin receptors in mice and men. Mol Immunol 2017;89:44-58. [PMID: 28600003 DOI: 10.1016/j.molimm.2017.05.019] [Cited by in Crossref: 48] [Cited by in F6Publishing: 47] [Article Influence: 9.6] [Reference Citation Analysis]
12 Stribos EG, van Werkhoven MB, Poppelaars F, van Goor H, Olinga P, van Son WJ, Damman J, Seelen MA. Renal expression of Toll-like receptor 2 and 4: Dynamics in human allograft injury and comparison to rodents. Molecular Immunology 2015;64:82-9. [DOI: 10.1016/j.molimm.2014.11.003] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
13 van Werkhoven MB, Damman J, van Dijk MC, Daha MR, de Jong IJ, Leliveld A, Krikke C, Leuvenink HG, van Goor H, van Son WJ. Complement mediated renal inflammation induced by donor brain death: role of renal C5a-C5aR interaction. Am J Transplant. 2013;13:875-882. [PMID: 23398742 DOI: 10.1111/ajt.12130] [Cited by in Crossref: 47] [Cited by in F6Publishing: 42] [Article Influence: 5.2] [Reference Citation Analysis]
14 Arias-Cabrales C, Rodriguez-Garcia E, Gimeno J, Benito D, Pérez-Sáez MJ, Redondo-Pachón D, Buxeda A, Burballa C, Crespo M, Riera M, Pascual J. Role of C5aR1 and C5L2 Receptors in Ischemia-Reperfusion Injury. J Clin Med 2021;10:974. [PMID: 33801177 DOI: 10.3390/jcm10050974] [Reference Citation Analysis]
15 Song Y, Wu KY, Wu W, Duan ZY, Gao YF, Zhang LD, Chong T, Garstka MA, Zhou W, Li K. Epithelial C5aR1 Signaling Enhances Uropathogenic Escherichia coli Adhesion to Human Renal Tubular Epithelial Cells. Front Immunol 2018;9:949. [PMID: 29765378 DOI: 10.3389/fimmu.2018.00949] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
16 Zhang T, Garstka MA, Li K. The Controversial C5a Receptor C5aR2: Its Role in Health and Disease. J Immunol Res 2017;2017:8193932. [PMID: 28706957 DOI: 10.1155/2017/8193932] [Cited by in Crossref: 9] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
17 Thorenz A, Derlin K, Schröder C, Dressler L, Vijayan V, Pradhan P, Immenschuh S, Jörns A, Echtermeyer F, Herzog C, Chen R, Rong S, Bräsen JH, van Kooten C, Kirsch T, Klemann C, Meier M, Klos A, Haller H, Hensen B, Gueler F. Enhanced activation of interleukin-10, heme oxygenase-1, and AKT in C5aR2-deficient mice is associated with protection from ischemia reperfusion injury-induced inflammation and fibrosis. Kidney Int 2018;94:741-55. [PMID: 29935951 DOI: 10.1016/j.kint.2018.04.005] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 5.8] [Reference Citation Analysis]
18 Burwick RM, Easter SR, Dawood HY, Yamamoto HS, Fichorova RN, Feinberg BB. Complement Activation and Kidney Injury Molecule-1–Associated Proximal Tubule Injury in Severe Preeclampsia. Hypertension 2014;64:833-8. [DOI: 10.1161/hypertensionaha.114.03456] [Cited by in Crossref: 19] [Cited by in F6Publishing: 8] [Article Influence: 2.4] [Reference Citation Analysis]
19 Li XX, Lee JD, Kemper C, Woodruff TM. The Complement Receptor C5aR2: A Powerful Modulator of Innate and Adaptive Immunity. J Immunol 2019;202:3339-48. [PMID: 31160390 DOI: 10.4049/jimmunol.1900371] [Cited by in Crossref: 44] [Cited by in F6Publishing: 40] [Article Influence: 22.0] [Reference Citation Analysis]
20 Li R, Coulthard LG, Wu MC, Taylor SM, Woodruff TM. C5L2: a controversial receptor of complement anaphylatoxin, C5a. FASEB J. 2013;27:855-864. [PMID: 23239822 DOI: 10.1096/fj.12-220509] [Cited by in Crossref: 126] [Cited by in F6Publishing: 125] [Article Influence: 12.6] [Reference Citation Analysis]